GB2292314A - Sweetening agents with amino acids - Google Patents

Sweetening agents with amino acids Download PDF

Info

Publication number
GB2292314A
GB2292314A GB9416570A GB9416570A GB2292314A GB 2292314 A GB2292314 A GB 2292314A GB 9416570 A GB9416570 A GB 9416570A GB 9416570 A GB9416570 A GB 9416570A GB 2292314 A GB2292314 A GB 2292314A
Authority
GB
United Kingdom
Prior art keywords
weight
sweetener
proline
hydroxyproline
glycine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB9416570A
Other versions
GB9416570D0 (en
Inventor
Jia Zengshen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EAST WELLSUM IND
Original Assignee
EAST WELLSUM IND
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EAST WELLSUM IND filed Critical EAST WELLSUM IND
Publication of GB9416570D0 publication Critical patent/GB9416570D0/en
Priority to PCT/IB1995/000245 priority Critical patent/WO1995027408A1/en
Priority to AU20817/95A priority patent/AU2081795A/en
Publication of GB2292314A publication Critical patent/GB2292314A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • A23L2/60Sweeteners
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20Synthetic spices, flavouring agents or condiments
    • A23L27/21Synthetic spices, flavouring agents or condiments containing amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30Artificial sweetening agents
    • A23L27/31Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30Artificial sweetening agents
    • A23L27/31Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
    • A23L27/32Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives containing dipeptides or derivatives

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A sweetening composition comprises a sweetening agent such as aspartame or saccharin and glycine and/or L-hydroxyproline. A preferred sweetener composition comprises a sweetening agent, glycine as a bulking agent and at least one of L-proline and L-hydroxyproline. The preferred embodiments comprise both L-proline and L-hydroxyproline.

Description

Title: A Sweetening Agent THE PRESENT INVENTION relates to novel sweetening agents and more particularly to novel sweetening agents comprising L-proline and/or L-hydroxyproline.
Glucose is a very important source of energy for all animals. As such, the sweet taste of glucose is extremely attractive. However, in many human societies in which glucose is plentiful, excessive consumption of glucose can lead to serious health problems such as obesity, tooth decay, high blood pressure and diabetes.
The problems with excessive glucose consumption became apparent, particularly in European and the U.S., following the Second World War when a plentiful supply of sugar lead to a significant proportion of the population suffering from overweight and diabetes. In response to this problem the search was commenced for sweeteners other than glucose, which sweeteners were able to impart sweetness to food products but which did not have the harmful calorific effects of glucose. The first sweetener to be found was saccharine. However, recently, saccharine is rapidly being replaced by the dipeptide aspartame, which does not have the bitter aftertaste of saccharine.
As the public awareness of the need for health and fitness increases, the demand for low calorie sweet foods has become greater. This has lead to the introduction of several different sweeteners, based on either saccharine or aspartame. The formulation of these sweeteners is often different, but in all cases the content of the sweetener itself is relatively low. This is primarily because the sweetness of both aspartame and saccharine is many times greater than glucose. Accordingly, to produce products that may be used in similar quantities and in a similar manner to glucose, bulking agents must be added to the sweetener to ensure that the final composition has the same sweetness to weight ratio as glucose.
Among the bulking agents which have been known to be used, are tartrate, calcium silicone, various carbohydrates, lactose, phenylalanine, glycine and leucine.
Several of these bulking agents have disadvantages, for instance in that they are calorific in themselves or that they are mild laxatives. Accordingly, there still remains a need for new sweetener compositions which at least provide an alternative to those already known and, preferably, provide further advantages over known sweetener compositions.
According to the present invention there is provided a sweetening agent comprising glycine, L-proline, and/or L-hydroxyproline.
According to the present invention there is provided a sweetener composition comprising a sweetening agent according to the present invention.
According to the present invention there is provided a sweetener composition comprising from 4/x% to 12/x% by weight of a sweetener, wherein x is the sweetness of the sweetener relative to glucose, from 80% to 97.5% by weight of glycine as a first bulking agent, and from 0.01% to 18% by weight of L-hydroxyproline.
L-hydroxyproline is an amino acid of the formula: LbHydroxyproline L-Trans-4-Hydroxy-Pyrrolidine-2-Formic Acid
Formula C5H9NO3 Molecular Wgt : 131.13 Nitrogen : 10.68% L-hydroxyproline is a natural component of collagen and has been found by the inventors to have several health benefits such as assisting in the digestion of fats, aiding formulation of haemoglobin and globulin, increasing the protection of the gastric wall, improving the absorption of food, increasing the metabolism of skin and improving the circulation of blood beneath the skin. This has the added benefit of reduction of wrinkles, and provides an antidecrepitude effect.
L-proline is an amino acid with the structure of: L - Proline L-Pyrrolin-2-Formic Acid
Formula : C5H3NO2 Molecular Wgt : 115.13 Nitrogen : 12.17% which is naturally found as a component of gelatinous tissue. It has been found, by the inventors, to have a substantial anti-oxidation effect as well as aiding malnutrition and protein deficiency. The inventors have also ascertained that L-proline aids in the healing of intestinal diseases and burns and, further, is suitable for use as a protein supplement following surgery.
In a particularly preferred embodiment of the present invention, the sweetener agent comprises both Lproline and L-hydroxyproline. It has been found that a combination of both these substances in a sweetener composition provide a synergistic effect, over and above the individual effects of the two components. The two components, acting together, provide the effect of improving the flavour of the composition. Glycine has the further advantageous effect of greater stability in which food produces, an effect which is enhanced by the presence of L-proline and/or L-hydroxyproline. The combination of L-proline and L-hydroxyproline also gives rise to memory enhancement of the consumer.
The sweetener itself may be any sweetener such as aspartame or saccharine, but is preferably aspartame.
The sweetener is present in the sweetener composition from 4/x to 12/ % by weight wherein x is the sweetness of the sweetener, relative to glucose. Thus, where glucose is taken as having a sweetness of 1, aspartame has a sweetness of 200. Accordingly, if aspartame is the sweetener used, it should be present in an amount from 2 to 6% by weight.
Glycine is used as a bulking agent. Glycine may be used alone or in combination with other bulking agents.
Glycine is a naturally occurring amino acid of the structure: Glycine Food goads Formula C2H5NO2 H2N - CH2 - COOH Molecular Wgt : 75.07 Molecular Wgt : 7.O7 Nltrogen : 18.6O% and is useful in the treatment of muscle weakness, false hypertrophy of muscles and nerve hyper-acidity. Glycine is also useful in suppression of gastric over-secretion which can result in gastritis.
A particularly preferred sweetener composition according to the present invention comprises from 2% to 6% by weight of aspartame, from 90% to 87.45% by weight of glycine, from 0.5% to 2% by weight of L-proline and from 0.5% to 2% by weight of L-hydroxyproline. This composition has the particular advantage that it comprises only natural amino acids (aspartame being a dipeptide) and further comprises the health benefits of the inclusion of Lhydroxyproline, L-proline and glycine, detailed above, together with the further synergistic advantages of the presence of L-hydroxyproline and L-proline together. This sweetener has about 1:1330th of the calories of normal sugar, and, by virtue of being composed solely of amino acids, is safe for consumption by diabetics and patients with a heat condition.
The composition of the present invention may be formulated in many forms such as granules, tablets, powders or liquid.
The present invention further comprises a method of manufacturing a sweetener agent according to the present invention, which method comprises the mixing of the components in the given proportions.
The present invention further provides the sweetener composition of the present invention for use as a medicament.
According to the present invention there is further provided a composition comprising extract of Tochu and a sweetener agent according to the present invention.
Preferably this composition comprises 1.5% to 4% Tochu extract from 85% to 95% by weight of glycine, from 1% to 3% by weight of L-proline and from 2% to 8% by weight of Lhydroxyproline.
Such a composition may be used as a beverage and may be sold in dehydrated form.
Tochu is a traditional and well-known Chinese herb which is greatly valued for its health giving properties.
It is known to contain several active ingredients including seventeen separate types of amino acids. Unfortunately, although Tochu is traditionally used in medicine and has now been discovered to have good nutritional properties, this herb, prepared in the traditional way, has a very strong and unpleasant taste. Thus, the amount used medicinally is the minimum necessary to aid in healing a patient, an amount too small for nutritional value to be gained.
The market at present contains many health foods using other Chinese herbs as ingredients. Such health foods have the problems of high sugar content, high calorie content and relatively low protein content as well as, in many cases, the use of artificial preservatives, colouring and flavourings. As such, these are not acceptable as health foods to many people and are unsuitable for consumers with problems such as obesity, dental caries and diabetes.
The beverage according to the present invention comprises the extract of Tochu, containing the active constituents of the herb, combined with the sweetening agent of the present invention, the mixture of glycine, Lproline and L-hydroxyproline. The health drink so produced provides all the benefits of Tochu but with a refreshing sweet taste, giving for the first time, a healthy and palatable way of gaining the benefits of Tochu.
Furthermore, the amino acids contained with the beverage act as a unique antioxidant and natural preservative.
The sweetening agent of the present invention, when used in the Tochu drink, do not merely add to the flavour and preservation of the drink. Glycine further provides an amino acid for use in the body, for conversion to other types of amino acids and subsequent protein synthesis and has been known to be able to suppress gastroxynsis by adjusting gastric juice secretion and improving food absorption. Furthermore, in combination with the Tochu extract it is able to induce liver cell multiplication, glycogen synthesis and improved bowel secretion. This allows the drink to be effective in the treatment of chronic hepatitis, cholecystitis, anorexia due to duodenal or stomach ulcers, indigestion, heartburn and abdominal distension.
L-hydroxyproline, in combination with Tochu extract ensures that the drink contains a full set of essential amino acids. L-hydroxyproline is also known to inhibit blood platelet agglomeration thus reducing the viscosity of the blood and lipids in the blood. It is also known to improve digestion by adjusting gastric juice secretion.
Furthermore, L-proline and L-hydroxyproline, in combination, are important components in colloidal proteins in the body allowing the health growth of skin, hair, bones and internal organisms. These two amino acids are relatively rare in the majority of food products and thus provide a beneficial supplement to the diet. Furthermore, the combination of L-proline and L-hydroxyproline improves the function of the central nervous system with many benefits such as memory enhancement. L-proline, in addition to L-hydroxyproline, also inhibits blood platelet agglomeration reducing the viscosity of the blood and the lipid content of the blood. Thus, the beverage of the present invention is useful for treating arterialsclerosis, hypertension, high fat content in the blood and obesity.
Finally, Tochu extract is known to be beneficial in improving the body's immune system. This will work in conjunction with L-hydroxyproline, L-proline and glycine, all of which are known to be useful in combatting streptococcus, colon bacillus and many other bacteria.
Overall, the drink using Tochu extract and the sweetening agent of the present invention is a potent health drink and nutritional aid.
To manufacture the health drink of the present invention, Tochu is first ground into powder and the active components thereof are extracted using several water/organic solvent extractions. After thorough filtration of the extract in solution, L-proline, Lhydroxyproline and glycine are added to the extract in the solution. The resulting mixed solution is dried, re-ground and packed in the form of powder for re-hydration to form the drink.
The present invention will further be described with reference to the following example.
EXAMPLE 1 1000g of the sweetener composition according to the present invention were formulated by mixing log of Lproline with lg of L-hydroxyproline. Subsequently 249g of glycine were added and mixed with the L-proline and Lhydroxyproline. Finally, 40g of aspartame were mixed with the other components to provide the sweetener composition, according to the present invention, in the form of a powder.
This sweetener composition, tested on animals, was shown to have an antioxidation effect, be useful for the treatment of malnutrition, protein deficiency, intestinal diseases and burns. The composition further aided fat digestion, formation of haemoglobin and globulin and protected the gastric wall, improved the absorption of food and increased the metabolism of the skin and improved the circulation of blood beneath the skin. Thus the sweetener composition was shown to decrease skin wrinkles and have an anti-decrepitude effect. Furthermore, the sweetener composition was shown to improve memory.
The sweetener composition so produced was also shown to give greater stability in the preservation of taste of hot food to which it is added, particularly when the food had cooled down, in comparison with other sweetener compositions.
The sweetener composition was found to have a calorie content of 0.024 kal per gramme.

Claims (16)

1. A sweetening agent comprising glycine, L-proline, and/or L-hydroxyproline.
2. A sweetener composition comprising a sweetening agent according to Claim 1 and a sweetener.
3. A sweetener composition according to Claim 2 comprising from 4/x to 12/x% by weight of a sweetener, wherein x is the sweetness of the sweetener relative to glucose, from 80% to 97.5% by weight of glycine as a first bulking agent and from 0.01% to 18% by weight of L-proline and/or L-hydroxyproline.
4. A composition according to Claim 2 or 3 comprising both L-proline and L-hydroxyproline.
5. A composition according to any one of Claims 2 to 4 further comprising a second bulking agent.
6. A composition according to any one of Claims 2 to 5 wherein the sweetener is aspartame.
7. A composition according to Claim 6 comprising from 2% to 6% by weight of aspartame.
8. A composition according to any one of Claims 2 to 7 comprising from 2% to 6% by weight of aspartame, from 90% to 87.45% by weight of glycine, from 0.5% to 2% by weight of L-proline and from 0.05% to 2% by weight of Lhydroxyproline.
9. A method of manufacturing a composition according to any one of Claims 2 to 8 comprising mixing the components in the given proportions.
10. A composition according to any one of Claims 2 to 8 for use as a medicament.
11. A composition comprising extract of Tochu and a sweetener agent according to Claim 1.
12. A composition according to Claim 11 comprising 1.5% to 4% by weight of Tochu extract, from 85% to 95% by weight of glycine, from 1% to 3% by weight of L-proline and from 2% to 8% by weight of L-hydroxyproline.
13. The composition of Claim 11 or 12 for use as a beverage.
14. The composition of any one of the preceding claims in dehydrated form.
15. A sweetener compsotion substantially as hereinbefore described.
16. Any novel feature or combination of features described herein.
GB9416570A 1994-04-11 1994-08-16 Sweetening agents with amino acids Withdrawn GB2292314A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB1995/000245 WO1995027408A1 (en) 1994-04-11 1995-04-06 Sweetening agent containing glycine, l-proline and/or l-hydroxyproline
AU20817/95A AU2081795A (en) 1994-08-16 1995-04-06 Sweetening agent containing glycine, l-proline and/or l-hydroxyproline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN94103980A CN1110112A (en) 1994-04-11 1994-04-11 Amino acid solid drink and preparation method thereof

Publications (2)

Publication Number Publication Date
GB9416570D0 GB9416570D0 (en) 1994-10-12
GB2292314A true GB2292314A (en) 1996-02-21

Family

ID=5031348

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9416570A Withdrawn GB2292314A (en) 1994-04-11 1994-08-16 Sweetening agents with amino acids

Country Status (2)

Country Link
CN (1) CN1110112A (en)
GB (1) GB2292314A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999030577A1 (en) * 1997-12-17 1999-06-24 The Nutrasweet Company Tabletop sweetener compositions comprising sweetener with extremely high potency
WO2006041668A1 (en) * 2004-10-04 2006-04-20 Mcneil Nutritionals, Llc No carb tabletop sweeteners substitute
WO2007061900A1 (en) * 2005-11-23 2007-05-31 The Coca-Cola Company High-potency sweetener composition with antioxidant and compositions sweetened therewith
WO2007061802A1 (en) * 2005-11-23 2007-05-31 The Coca-Cola Company High-potency sweetener for hydration and sweetened hydration composition
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4913410B2 (en) 2004-01-14 2012-04-11 味の素株式会社 Foods containing glycine and uses thereof
CN113080355A (en) * 2021-04-23 2021-07-09 江苏金维氨生物工程有限公司 Amino acid solid beverage capable of rapidly supplementing nutrition and production process thereof

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963736A1 (en) * 1969-12-19 1971-06-24 Haarmann & Reimer Gmbh Improving taste of saccharin
FR2077736A2 (en) * 1970-02-10 1971-11-05 Cerc Glucose-artificial sweetener mixtures - for prevention of hyperlipemi
US3833745A (en) * 1971-06-01 1974-09-03 J Lontz Sweetening composition
WO1982003773A1 (en) * 1981-04-27 1982-11-11 Baxter Travenol Lab Dialysis solution containing glucose,amino acids & insulin
EP0122400A1 (en) * 1983-02-21 1984-10-24 Takeda Chemical Industries, Ltd. Sweetener composition and sweetening method
US4486455A (en) * 1982-08-31 1984-12-04 Chimicasa Gmbh Water-soluble sweetening tablets
EP0148680A1 (en) * 1983-12-20 1985-07-17 Synthelabo Amino-acid solutions
GB2169601A (en) * 1985-01-14 1986-07-16 Tate & Lyle Plc Stabilisation of sucralose
EP0226332A1 (en) * 1985-11-18 1987-06-24 Beecham Group Plc Veterinary compositions
US4683233A (en) * 1984-03-08 1987-07-28 Bayer Aktiengesellschaft Salts of 2-keto-2H, 3H-1,2-benzisothiazole 1,1-dioxide as microbicides
WO1988001861A1 (en) * 1986-09-17 1988-03-24 Baxter Travenol Laboratories, Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic, vascular, cardiovascular, and/or thrombotic diseases

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963736A1 (en) * 1969-12-19 1971-06-24 Haarmann & Reimer Gmbh Improving taste of saccharin
FR2077736A2 (en) * 1970-02-10 1971-11-05 Cerc Glucose-artificial sweetener mixtures - for prevention of hyperlipemi
US3833745A (en) * 1971-06-01 1974-09-03 J Lontz Sweetening composition
WO1982003773A1 (en) * 1981-04-27 1982-11-11 Baxter Travenol Lab Dialysis solution containing glucose,amino acids & insulin
US4486455A (en) * 1982-08-31 1984-12-04 Chimicasa Gmbh Water-soluble sweetening tablets
EP0122400A1 (en) * 1983-02-21 1984-10-24 Takeda Chemical Industries, Ltd. Sweetener composition and sweetening method
EP0148680A1 (en) * 1983-12-20 1985-07-17 Synthelabo Amino-acid solutions
US4683233A (en) * 1984-03-08 1987-07-28 Bayer Aktiengesellschaft Salts of 2-keto-2H, 3H-1,2-benzisothiazole 1,1-dioxide as microbicides
GB2169601A (en) * 1985-01-14 1986-07-16 Tate & Lyle Plc Stabilisation of sucralose
EP0226332A1 (en) * 1985-11-18 1987-06-24 Beecham Group Plc Veterinary compositions
WO1988001861A1 (en) * 1986-09-17 1988-03-24 Baxter Travenol Laboratories, Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic, vascular, cardiovascular, and/or thrombotic diseases

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999030577A1 (en) * 1997-12-17 1999-06-24 The Nutrasweet Company Tabletop sweetener compositions comprising sweetener with extremely high potency
WO2006041668A1 (en) * 2004-10-04 2006-04-20 Mcneil Nutritionals, Llc No carb tabletop sweeteners substitute
WO2007061900A1 (en) * 2005-11-23 2007-05-31 The Coca-Cola Company High-potency sweetener composition with antioxidant and compositions sweetened therewith
WO2007061802A1 (en) * 2005-11-23 2007-05-31 The Coca-Cola Company High-potency sweetener for hydration and sweetened hydration composition
US8962058B2 (en) 2005-11-23 2015-02-24 The Coca-Cola Company High-potency sweetener composition with antioxidant and compositions sweetened therewith
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith

Also Published As

Publication number Publication date
CN1110112A (en) 1995-10-18
GB9416570D0 (en) 1994-10-12

Similar Documents

Publication Publication Date Title
US6136367A (en) Composition and its use as a food supplement or for lowering lipids in serum
AU2437101A (en) Nutritional composition, methods of producing said composition and methods of using said composition
DE2621000A1 (en) NUTRITIONAL DEFICIENCY PREVENTION COMPOSITION
JPH09191852A (en) Healthy food
CN106858244A (en) Maize oligopeptide sobering-up beverage and preparation method thereof
CN112205559A (en) Composition containing eucommia ulmoides and mulberry leaves and application
WO1995027408A1 (en) Sweetening agent containing glycine, l-proline and/or l-hydroxyproline
JPH08275752A (en) Mental/physical stress-remedying food
GB2292314A (en) Sweetening agents with amino acids
KR100759222B1 (en) Method for preparing a drink with red ginseng and vinegar
JP4406780B2 (en) Method for producing anti-influenza virus agent and other drugs using active ingredient of birch moth, and method for producing health food and drink product
KR101212706B1 (en) Production method of anti-obesity beverage using seaweed extracts
JP2006503099A (en) Composition for reducing caloric intake
CN111234994A (en) Preparation method of health wine
CN106721771A (en) One kind relaxes bowel health drink and preparation method thereof
CN113974162B (en) Chinese prescription pear syrup bird nest and preparation method thereof
KR100425832B1 (en) Manufacturing method of health enriched food used dehydrated a snake head and dehydrated marine products
CN115226820A (en) Whitening and sugar resisting drink composition
KR100375366B1 (en) A process for preparing a ginseng beverage with a taste of cola
KR20210041387A (en) A natural tea removing the effect of hangover contained the extract material in arrowroot blossoms and Plantago ovata
CN110179034A (en) A kind of sea-buckthorn banana solid beverage of strengthen immunity and preparation method thereof
KR100438197B1 (en) Brine of duck and that of manufacturing method
JP2852333B2 (en) Arhat Jelly
KR102671658B1 (en) Dietary fiber composition for promoting defecation and improving cholesterol containing psyllium hull and manufacturing method thereof
JP4435882B2 (en) Alcohol absorption inhibiting composition

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)